Medicinal Products

MabThera

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name MabThera
Active Substance rituksimab
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L01XC02
Medicinal product marketed in the Croatia Da
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Educational materials
for healthcare professionals
Vodič o izgledu, čuvanju, rukovanju i primjeni, verzija 2
Kartica usporedbe supkutane i intravenske primjene, verzija 2
Knjižica za zdravstvene radnike, verzija 6
Educational materials
for patients / caregivers
Priručnik za bolesnike, verzija 5
Kartica za bolesnike
Back